The Precision Medicine and Personalized Healthcare session address a rapidly evolving healthcare paradigm. With advancements in genomics and data analytics, it tailor’s treatments to individual patient characteristics. Market demand is surging as patients seek more effective, less invasive therapies. The market has seen increased investment in research, diagnostic tools, and targeted therapeutics. However, challenges such as data privacy, integration of complex technologies, and regulatory compliance remain. Despite this, the market's trajectory is optimistic, driven by a growing understanding of molecular mechanisms, improved patient outcomes, and the potential to revolutionize disease management across diverse populations.
All accepted abstracts will be published in respective Allied Academies Journals.
Abstracts will be provided with Digital Object Identifier by
